Welcome to our dedicated page for inTEST news (Ticker: INTT), a resource for investors and traders seeking the latest updates and insights on inTEST stock.
InTest Corporation reports developments as a global supplier of test and process technology solutions used in manufacturing and testing across semiconductor, Auto/EV, defense/aerospace, industrial, life sciences, and safety/security markets. Company updates commonly cover quarterly results, orders, backlog, gross margin, product mix, and demand across diversified end markets.
Recurring news also includes leadership and board changes, investor-conference participation, acquisition integration, and customer orders tied to businesses such as Alfamation. Product-focused updates describe functional test systems, thermal, mechanical, and electronic solutions, and initiatives to expand cross-business selling, manufacturing efficiency, supply-chain performance, and targeted market reach.
InTest Corporation (NYSE American: INTT) will participate in the Oppenheimer 11th Annual Emerging Growth Conference with virtual investor meetings on February 3, 2026. Nick Grant, President & CEO, and Duncan Gilmour, CFO, will host one-on-one and small-group investor meetings.
Investors should contact their Oppenheimer representative to register for virtual meetings.
InTest Corporation (NYSE American: INTT) said its President & CEO Nick Grant and CFO Duncan Gilmour will participate in the 14th Annual NYC Summit on December 16, 2025 at Mastro’s Steakhouse in New York.
Presentations begin at 1:00 p.m. ET in a round-robin small-group format. The presentation file will be posted the morning of December 16, 2025 under Events and Presentation in the Investors Relations section at https://www.intest.com/investor-relations.
InTest (NYSE American: INTT) announced a follow-on $3.7 million order from an existing medical device customer for Alfamation, an InTest business.
Alfamation will supply multiple in-line, conveyor-based functional test systems with high-precision instruments and fixtures to automate high-volume testing, supporting a stated goal of testing 50 million devices a year. The order advances InTest's diversification into life sciences beyond its automotive focus and emphasizes Alfamation's PCB-level functional-test capability for products that cannot be evaluated when fully assembled.
InTest Corporation (NYSE American: INTT) announced that President & CEO Nick Grant and CFO Duncan Gilmour will present and host investor meetings at the 17th Annual Southwest Ideas Conference on Wednesday, November 19, 2025.
The live presentation begins at 7:55 a.m. Central / 8:55 a.m. Eastern. A live audio webcast with accompanying slides will be available on the INTT Investor Relations site, and an archive of the presentation will be posted at the same link following the conference.
InTest (NYSE: INTT) reported Q3 2025 results for the quarter ended September 30, 2025. Revenue was $26.2M, down 13.3% YoY due to late-quarter shipment delays that have since been fulfilled. Orders surged 34.2% YoY to $37.6M, and backlog rose to $49.3M (30.1% higher than June 30, 2025), with ~55% of backlog expected to ship beyond Q4 2025. The company generated $3.5M cash from operations, ended the quarter with $21.1M cash, and reduced total debt to $8.9M. Operating loss was $1.2M, net loss $0.9M or $(0.08) diluted EPS; Adjusted EPS was $(0.02) and Adjusted EBITDA was $0.4M. Q4 2025 guidance: revenue of $30M–$32M, gross margin ~43%, and operating expenses of $12.3M–$12.7M.
InTest (NYSE American: INTT) will release its third quarter 2025 financial results before market open on Wednesday, November 5, 2025. The company will host a conference call and webcast the same day at 8:30 a.m. Eastern Time to review financial and operating results, corporate strategy and outlook, followed by a Q&A session.
Dial-in: (201) 689-8263. Webcast, slides, replay and transcript: available at InTest.com. Telephonic replay available from 12:30 p.m. ET on Nov 5 through Nov 19, 2025 (replay dial (412) 317-6671, replay PIN 13756099).
InTest Corporation (NYSE American: INTT), a global supplier of innovative test and process technology solutions, announced its participation in two upcoming investor conferences. The company's executives will attend:
1. The H.C. Wainwright 27th Annual Global Investment Conference on September 10, 2025, in New York, featuring a presentation at 12:00 p.m. ET
2. The Lake Street Best Ideas BIG9 Growth Conference on September 11, 2025, in New York, consisting of one-on-one investor meetings
InTest Corporation (NYSE American: INTT), a global supplier of test and process technology solutions, announced its participation in the upcoming Needham Semiconductor and Semi Cap 1x1 Conference. The company's executives, Nick Grant (President & CEO) and Duncan Gilmour (CFO), will conduct virtual investor meetings on August 21, 2025.
InTest serves various key markets including semiconductor, automotive/EV, defense/aerospace, industrial, life sciences, and safety/security sectors.
InTest Corporation (NYSE American: INTT) has secured a significant $2.6 million order from a prime defense contractor for multiple thermal test systems. The systems, designed and manufactured by InTest's Environmental Technologies Division, will be used for ultra-low temperature testing of electronic systems in missile production processes.
The order will be fulfilled through shipments spanning a six-month period starting in Q4 2025. President and CEO Nick Grant emphasized that this order validates their Environmental Technologies' solutions for critical applications and supports their projected quarter-over-quarter growth throughout the year.
[ "Secured significant $2.6 million defense contract order", "Order supports projected quarter-over-quarter growth", "Validates company's technology solutions in critical defense applications", "Six-month delivery timeline provides clear revenue visibility" ]InTest Corporation (NYSE American: INTT) reported mixed Q2 2025 results with some improvements amid challenging market conditions. Orders increased 10% sequentially to $27.8 million, driven by strength in auto/EV and life sciences markets. Revenue grew 6% sequentially to $28.1 million, while gross margin expanded 110 basis points to 42.6%.
The company narrowed its operating loss to $0.9 million and net loss to $0.5 million, with Adjusted EBITDA of $1.3 million. InTest reduced total debt by $1.7 million to $10.1 million and secured a covenant waiver through Q1 2026. The company forecasts Q3 2025 revenue between $28-30 million with stable gross margins.